Clinical Experts Speak: From Gene Therapy to Digital Registries

Navitas Life Sciences has vast experience and expertise to discuss strategies in well structured webinars that are a must watch. If you missed watching them live, then here is your chances to watch the best webinars in 2022.

1) Risk Mitigation in Gene Therapy Clinical Trials Development

Download our On-demand webinar to listen to our subject matter experts as they explore key themes regarding

• Risk Mitigation in Gene Therapy Clinical Trials
• Gene Therapy in Diabetes
• Opportunities and Challenges in Gene Therapy Clinical Trials

Dr. Narendra Chirmule

CEO
SymphonyTech

Dr. Kirk Hammond

Professor of Medicine,
UC San Diego and Founder
Renova Therapeutics

Dr. Atul Gupta

Vice President-Medical & Scientific Affairs
Navitas Life Sciences

Download the On-demand Webinar Now

2) Don’t Treat Your Registry like your Clinical Trials

Watch this webinar to listen to our subject matter experts as they explore key themes regarding

• How Registries are different from Clinical Trials?
• How to effectively support the development of a Registry?
• Which systems and strategies are necessary to develop a successful Registry

Yun Lu

Chief Science & Innovation Officer
Navitas Clinical Research

Sarah Lawrence

Sr. Clinical Project Manager
Navitas Clinical Research

Download the On-demand Webinar Now

3) Digital Registry Platforms - Considerations for EHR/EDC Integration

In this webinar, our subject matter experts explores key themes regarding

• What goes into Registry platform planning
• How EHR - EDC integration can accelerate your registry study
• How to obtain Optimized Digital Solutions through the data coordinating center

Yun Lu

Chief Science & Innovation Officer
Navitas Clinical Research

Cal Collins

Chief Executive Officer
OpenClinica

Andra Matthews

Senior Clinical Project Manager
Navitas Clinical Research

Download the On-demand Webinar Now

Navitas Clinical Research (a part of Navitas Life Sciences) has over 30 years of expertise in managing early through late phase clinical trials and registries & other observational studies. Our clients include US Federal Government institutes and non-profits.

4) Innovation and Optimization in Early Phase Oncology Studies: Opportunity for speed, success and savings

Listen to our On-demand webinar as our subject matter experts explores key themes regarding

• How applying innovative designs in early phase oncology trials can accelerate timelines and reduce costs
• How to focus development on the most promising agents at the right doses in the right indications for the right patients
• Simple strategies on Dose Escalation: A legacy of statistical innovation
• Expert insights on Novel endpoints to sail through dose expansion and proof of concept

Dr. Atul Gupta

Vice President-Medical & Scientific Affairs
Navitas Life Sciences

Venkatesan Balu

Associate Director – Global Data Sciences
Navitas Life Sciences

Download the On-demand Webinar Now

GAIN FROM NAVITAS LIFE SCIENCES’ VAST EXPERIENCE

Navitas Life Sciences supports small to large pharma, biotech and devices companies, generics manufacturers, and U.S federal agencies like the Centers for Disease Control and Prevention (CDC) and The U.S. Department of Defense (DoD), with 30+ years of rich experience across 550+ phase I-IV clinical trials, 20+ therapeutic areas expertise, and delivering platform-driven full-service Clinical, Regulatory, Safety solutions and Clinical Registry services.

To learn more about our services and solutions, reach out to us at This email address is being protected from spambots. You need JavaScript enabled to view it.